GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

ExpreS2ion Biotech Holding EXPRS2.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.91

-1.51%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

ExpreS2ion Biotech Holding — daily EXPRS2

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View ExpreS2ion Biotech Holding on TradingView ↗
Market value
SEK 3.2m
Last close × shares
Volume
126.5k
Shares, 9 Nov 2026

About ExpreS2ion Biotech Holding

Its shares trade on Nasdaq Stockholm under the ticker EXPRS2.ST. It has been listed since 29 July 2016. In the fiscal year to 31 December 2025, it reported revenue of SEK 3.7m and a net loss of SEK 38.1m. At that date it held total assets of SEK 65.1m and shareholders' equity of SEK 35.7m.

Expres2ion Biotech Holding AB engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer. The company is headquartered in Helsingborg, Skane. The company went IPO on 2016-07-29. The firm specializes in developing cell lines and processes based on a non-viral Drosophila S2 cells expression system. The firm's ExpreS2 recombinant protein expression platform supports all phases of drug discovery, research and development and manufacturing. ExpreS2 is a non-viral insect cell expression system that establishes stable polyclonal pools that provide high-protein expression levels without selection pressure. The system is designed for transient or stable transfections using vector deoxyribonucleic acid containing a hybrid promoter. The company also ensures high cell density without aggregation or toxic metabolite build-up issues. Through the joint venture AdaptVac ApS, the Company applies a Plug-and-Play Virus Like Particle technology for development of therapeutic and prophylactic vaccines within oncology, infectious diseases and immunological disorders.

Figures and description from our data supplier, not checked against the company's own report.

More about ExpreS2ion Biotech Holding →

Latest on ExpreS2ion Biotech Holding

Our reporting

Next results

12 Nov 2026

Due on 12 Nov 2026.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is ExpreS2ion Biotech Holding's ticker?

ExpreS2ion Biotech Holding trades as EXPRS2.ST on Nasdaq Stockholm, under ISIN SE0023261292.

What was ExpreS2ion Biotech Holding's last closing price?

0.91 on 9 Nov 2026. The figure is in SEK and is never converted.

When does ExpreS2ion Biotech Holding next report results?

Results are expected on 12 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.